Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study.

Pandora L WanderElliott LowyLauren A BesteLuis Tulloch-PalominoAnna KorpakAlexander C PetersonSteven E KahnGoodarz DanaeiEdward J Boyko

Published in: BMJ open (2022)

Associations of statin use with lower adverse 30-day outcomes are weaker among individuals who tested positive for SARS-CoV-2 compared with individuals without a positive test, indicating that statins do not exert SARS-CoV-2 specific effects.

Keyphrases

sars cov
cardiovascular disease
respiratory syndrome coronavirus
coronary artery disease
emergency department
adipose tissue
low density lipoprotein
metabolic syndrome
skeletal muscle
drug induced